Benedikt Stefansson
Investor Relations Kontakt bei ALVOTECH
Ursprung des Netzwerks ersten Grades von Benedikt Stefansson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
23
| Public Company | Biotechnology | 23 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Benedikt Stefansson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Iceland | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| LOTUS PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| Reykjavik University | College/University | Director/Board Member Human Resources Officer | |
| FUJI PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Adalvo Ltd.
 Adalvo Ltd. Pharmaceuticals: MajorHealth Technology Adalvo Ltd. is a pharmaceutical company with headquarters in an undisclosed location and additional offices in over 15 countries. The private company is based in an undisclosed location and has subsidiaries in over 15 countries, including the United States and India. The Maltese company takes a unique and customized approach to help its partners achieve their business goals in the dynamic pharmaceutical sector. Adalvo is committed to accelerating the growth and development of its employees and local communities while striving for excellence in all its endeavors. The company's purpose-driven culture is focused on improving the lives of patients worldwide. Adalvo has a dynamic leadership team with significant experience and industry know-how. The CEO of the company is Anil Okay. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Alvogen Emerging Markets Holdings Ltd.
 Alvogen Emerging Markets Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Kunwha Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member | ||
Alvogen Iceland ehf
 Alvogen Iceland ehf Pharmaceuticals: MajorHealth Technology Alvogen Iceland ehf develops, manufactures and distributes generic pharmaceutical products. It offers Eradizol, Kalmente, Eubiotic, Windi, Zinkspray, and Aftamed. The company was founded in 2010 and is headquartered in Reykjavik, Iceland. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KUNWHA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
Alvogen Pharma US, Inc.
 Alvogen Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Alvogen Pharma US, Inc. engages in the development, manufacturing and distributing generic, brand, over-the-counter brands and biosimilar products. The company was founded in March 2012 and is headquartered in Morristown, NJ. | Pharmaceuticals: Major | Chief Executive Officer President | |
| Sandoz Biopharmaceuticals | Corporate Officer/Principal | ||
Almaject, Inc.
 Almaject, Inc. Pharmaceuticals: MajorHealth Technology Part of Alvogen, Inc., Almaject, Inc. develops, acquires, and commercializes pharmaceutical products. The company is based in Morristown, NJ. | Pharmaceuticals: Major | President | |
| The University of Newcastle | College/University | Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Norwich Pharmaceuticals, Inc.
 Norwich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Norwich Pharmaceuticals Inc. provides contract manufacturing and clinical services for the pharmaceuticals industry. It offers services, including clinical trial production support, quality assurance and control and regulatory compliance. The company was founded in 1887 and is headquartered in Norwich, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Kirkland & Ellis LLP
 Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Kirkland & Ellis LLP provides legal services. It counsels clients in litigation, corporate and tax, intellectual property and restructuring matters. The firm offers intellectual property, antitrust and competition, international trade and national security, real estate and tax, benefits and estate planning services. The company was founded in 1909 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Auregen Biotherapeutics SA
 Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Packaged Software | Chief Executive Officer | |
| University of Warwick | College/University | Masters Business Admin | |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | ||
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BONESUPPORT HOLDING AB | Medical Specialties | Chief Executive Officer | |
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Executive Officer | |
Bone Support Incentive AB
 Bone Support Incentive AB Real Estate DevelopmentFinance Part of BONESUPPORT HOLDING AB, Bone Support Incentive AB provides real estate services. The company is based in Lund, Sweden. | Real Estate Development | Chairman | |
Auregen Biotherapeutics, Inc.
 Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Miscellaneous Commercial Services | Chief Executive Officer | |
InterAx Biotech AG
 InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Chairman | |
| Lögmannafélag Íslands | Corporate Officer/Principal | ||
Deloitte & Touche hf
 Deloitte & Touche hf Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche hf provides accounting and financial advice. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Alvogen Korea Holdings Ltd.
 Alvogen Korea Holdings Ltd. Pharmaceuticals: MajorHealth Technology Alvogen Korea Holdings Ltd. is a holding company, which engages in the development and manufacture of pharmaceutical products. Its products include medicine for urogenital system, circulatory system, diabetes, digestive system, nephrology division, dermatological division, respiratory system, antibiotics, hormone drug, health supplements, and pain reliever. The company was founded in 1958 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Alvogen Asia Pacific Holdings Ltd.
 Alvogen Asia Pacific Holdings Ltd. Pharmaceuticals: MajorHealth Technology Alvogen Asia Pacific Holdings Ltd. develops and manufactures drugs. The company is headquartered in Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
Alvogen Group, Inc.
 Alvogen Group, Inc. Pharmaceuticals: MajorHealth Technology Part of Alvogen, Inc., Alvogen Group, Inc. is a pharmaceutical company that offers a unique portfolio of high-quality and difficult-to-make pharmaceutical products. The company is based in Pine Brook, NJ. The company's targeted growth strategy is fueled by providing affordable generic medications that help reduce healthcare costs globally. | Pharmaceuticals: Major | Director/Board Member | |
| Case Western Reserve University School of Law | College/University | Graduate Degree | |
| University of Lakehead | College/University | Undergraduate Degree | |
| NEWBURY PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
| Rutgers University, Camden | College/University | Undergraduate Degree | |
| Mannauður | Chairman | ||
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Maine | College/University | Undergraduate Degree | |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| North Carolina State University | College/University | Undergraduate Degree | |
| Efla Oy | Human Resources Officer | ||
| University of Leicester | College/University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 19 |
| Island | 7 |
| Vereinigtes Königreich | 5 |
| Schweden | 5 |
| Südkorea | 4 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Technology Services | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 65 |
| Corporate Officer/Principal | 46 |
| Chief Executive Officer | 26 |
| Chairman | 18 |
| Undergraduate Degree | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Vilhelm Wessman | 23 |
| Linda McGoldrick | 21 |
| Tomas Ekman | 19 |
| Richard Davies | 15 |
| Helga Zharov | 15 |
| Árni Harðarson | 13 |
| Anil Okay | 12 |
| Lisa Graver | 10 |
| Hirofumi Imai | 8 |
| Ann Merchant | 8 |
| Mark Levick | 7 |
| Sigridur Elin Gudlaugsdottir | 7 |
| Joel Morales | 6 |
| Hafrun Fridriksdottir | 6 |
| Faysal Kalmoua | 6 |
- Börse
- Insiders
- Benedikt Stefansson
- Unternehmensverbindungen